Immunoclin (Immunoclin) Receivables Turnover : 0.12 (As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Immunoclin's Revenue for the three months ended in Oct. 2014 was $0.01 Mil. Immunoclin's average Accounts Receivable for the three months ended in Oct. 2014 was $0.04 Mil. Hence, Immunoclin's Receivables Turnover for the three months ended in Oct. 2014 was 0.12.

Immunoclin Receivables Turnover Historical Data

The historical data trend for Immunoclin's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Receivables Turnover Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Receivables Turnover

5.38

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Receivables Turnover	Get a 7-Day Free Trial									-	-	-	-	0.12

Competitive Comparison of Immunoclin's Receivables Turnover

For the Biotechnology subindustry, Immunoclin's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immunoclin's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunoclin's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Immunoclin's Receivables Turnover falls into.

Immunoclin Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Immunoclin's Receivables Turnover for the fiscal year that ended in Jan. 2014 is calculated as

	Receivables Turnover (A: Jan. 2014 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Jan. 2014 )	/ (	(Accounts Receivable (A: Jan. 2013 )	+	Accounts Receivable (A: Jan. 2014 ))	/	count )
=	0	/ (	(0.034	+	0.014)	/	2 )
=	0	/	0.024
=	N/A

Immunoclin's Receivables Turnover for the quarter that ended in Oct. 2014 is calculated as

	Receivables Turnover (Q: Oct. 2014 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Oct. 2014 )	/ (	(Accounts Receivable (Q: Jul. 2014 )	+	Accounts Receivable (Q: Oct. 2014 ))	/	count )
=	0.005	/ (	(0.015	+	0.067)	/	2 )
=	0.005	/	0.041
=	0.12

Immunoclin (GREY:IMCL) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Immunoclin Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Immunoclin's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines